165 related articles for article (PubMed ID: 29949506)
1. Increased serum concentrations of soluble ST2 predict mortality after burn injury.
Hacker S; Dieplinger B; Werba G; Nickl S; Roth GA; Krenn CG; Mueller T; Ankersmit HJ; Haider T
Clin Chem Lab Med; 2018 Nov; 56(12):2079-2087. PubMed ID: 29949506
[TBL] [Abstract][Full Text] [Related]
2. Soluble Suppression Of Tumorigenicity-2 Predicts Hospital Mortality in Burn Patients: An Observational Prospective Cohort Pilot Study.
Ruiz-Castilla M; Bosacoma P; Dos Santos B; Baena J; Guilabert P; Marin-Corral J; Masclans JR; Roca O; Barret JP
Shock; 2019 Feb; 51(2):194-199. PubMed ID: 29642231
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
Chen Y; Qian J
J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
[TBL] [Abstract][Full Text] [Related]
4. Serum ST2 as a potential prognostic biomarker for traumatic brain injury.
Du Q; Weng JF; Luo LF; Cen M; Yu WH; Zheng YK; Hu W; Pan JW; Dong XQ
Clin Chim Acta; 2018 Dec; 487():145-152. PubMed ID: 30266513
[TBL] [Abstract][Full Text] [Related]
5. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
[TBL] [Abstract][Full Text] [Related]
6. Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke.
Chen W; Lin A; Yu Y; Zhang L; Yang G; Hu H; Luo Y
Clin Lab; 2018 Sep; 64(9):1349-1356. PubMed ID: 30274001
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) study.
Dieplinger B; Egger M; Koehler W; Firlinger F; Poelz W; Lenz K; Haltmayer M; Mueller T
Clin Chim Acta; 2012 Mar; 413(5-6):587-93. PubMed ID: 22155704
[TBL] [Abstract][Full Text] [Related]
8. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of low interleukin-33 in critically ill patients.
Krychtiuk KA; Stojkovic S; Lenz M; Brekalo M; Huber K; Wojta J; Heinz G; Demyanets S; Speidl WS
Cytokine; 2018 Mar; 103():109-113. PubMed ID: 28974430
[TBL] [Abstract][Full Text] [Related]
10. Soluble ST2 has a prognostic role in patients with suspected sepsis.
Hur M; Kim H; Kim HJ; Yang HS; Magrini L; Marino R; Cardelli P; Di Somma S;
Ann Lab Med; 2015 Nov; 35(6):570-7. PubMed ID: 26354344
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.
Dieplinger B; Egger M; Leitner I; Firlinger F; Poelz W; Lenz K; Haltmayer M; Mueller T
J Crit Care; 2016 Aug; 34():38-45. PubMed ID: 27288608
[TBL] [Abstract][Full Text] [Related]
12. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of soluble ST2 levels predicted fatality and were involved in coagulopathy in dengue fever in the elderly.
Hsieh CC; Hong MY; Ho TS; Liu CC; Perng GC; Chuang CC
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007974. PubMed ID: 31877138
[TBL] [Abstract][Full Text] [Related]
14. Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy.
Zhang Z; Wang H; Zhang L; Crew R; Zhang N; Liu X; Jiang Y
J Immunol Res; 2016; 2016():6540937. PubMed ID: 27900334
[No Abstract] [Full Text] [Related]
15. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
Thiébaut R; Hue S; Le Marec F; Lelièvre JD; Dupon M; Foucat E; Lazaro E; Dabis F; Duffau P; Wittkop L; Surenaud M; Pellegrin I; Lacabaratz C; Bonnet F; Lévy Y;
AIDS; 2017 Nov; 31(17):2355-2365. PubMed ID: 29068834
[TBL] [Abstract][Full Text] [Related]
16. Increased soluble ST2 and IL‑4 serum levels are associated with disease severity in patients with membranous nephropathy.
Zhang Z; Liu X; Wang H; Qu Z; Crew R; Zhang N; Jiang Y
Mol Med Rep; 2018 Feb; 17(2):2778-2786. PubMed ID: 29207152
[TBL] [Abstract][Full Text] [Related]
17. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
[TBL] [Abstract][Full Text] [Related]
18. Increased serum concentrations of soluble ST2 are associated with pulmonary complications and mortality in polytraumatized patients.
Haider T; Simader E; Hacker P; Ankersmit HJ; Heinz T; Hajdu S; Negrin LL
Clin Chem Lab Med; 2018 Apr; 56(5):810-817. PubMed ID: 29341938
[TBL] [Abstract][Full Text] [Related]
19. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
20. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration.
Homsak E; Ekart R
Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
